Immunohistochemistry revealed a major elevation in the number of cleaved caspase-3 positive tumor cells after treatment regimens involving mEHT, which was confirmed by image segmentation based digital image analysis (Figure 2C). The gene discussed is CASP3; the disease is neoplasm.